How fast does the halo sign vanish after steroids in GCA?
Part of Brain & nervous system, Heart & circulation, Immune system & allergy, Skin clinical trials.
This trial is for people newly diagnosed with giant cell arteritis (GCA) who have a 'halo' sign on their temporal artery ultrasound. It will study how quickly the halo disappears after starting steroid treatment, helping doctors understand the best way to use steroids for this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years old or older.
- You have been newly diagnosed with giant cell arteritis (GCA) and an ultrasound showed a 'halo' sign on your temporal artery.
- You have not yet started any steroid treatment for GCA.
- You have not had a temporal artery biopsy before.
- You do not have other types of blood vessel inflammation or certain infections (like syphilis or tuberculosis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a drug called bosentan, which is usually used for other conditions, can help calm the inflammation in giant cell arteritis and reduce symptoms. You would take it in addition to your usual treatment, and it might help lower the dose of steroids you need.
This trial tests a fast-track process to quickly diagnose giant cell arteritis (GCA), a condition that causes blood vessel inflammation. It may help patients get the right care faster.
This study uses ultrasound, a biopsy of the temple artery, and blood tests to improve how giant cell arteritis (GCA) is diagnosed, monitored, and predicted. It may help doctors find better ways to manage this condition.
This study tracks patients with giant cell arteritis (GCA, a blood vessel inflammation affecting older adults) who are in remission and tapering their steroid medications. Researchers will monitor disease activity through blood tests and patient questionnaires to understand if their condition stays stable as they reduce treatment.
This study tracks how quickly your C-reactive protein (CRP) level, a marker of inflammation, drops after you start taking steroids (glucocorticoids) for giant cell arteritis. The goal is to find better ways to monitor treatment response in this condition.
This trial uses an ultrasound to check for swelling around the optic nerve in people who may have giant cell arteritis (GCA). It aims to see if this test can help diagnose GCA faster.
Hear when a new Doppler Ultrasound trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.